No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Why Is Novartis AG (NVS) Among the Best European Dividend Stocks To Buy Now?
RAPT Rockets 180% on Licensing Deal, $150M Private Placement
Novartis Says 330 Jobs Hit as It Closes MorphoSys Sites
European Stocks That Trade Cheaper Than U.S. Peers
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Sanofi: Kress Was the CEO of MorphoSys From 2019 Until It Was Acquired by Novartis in 2024